Helen Petousis-Harris

An epidemic of Group B meningococcal disease in New Zealand prompted the development of a vaccine, which also provides moderate protection against gonorrhoea. from www.shutterstock.com

More reason to use Meningococcal B vaccine – it could also cut the Clap

As the WHO calls for urgency to address antibiotic resistance in gonorrhoea, new research shows that a vaccine developed against an unrelated disease offers protection.

Contact Helen for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision